Literature DB >> 1582446

Effect of endothelin on normal and diseased human coronary arteries.

A H Chester1, G S O'Neil, S P Allen, T N Luu, S Tadjkarimi, M H Yacoub.   

Abstract

We have examined the action of endothelin on healthy and diseased human epicardial coronary arteries to assess its possible role in coronary vascular disorders such as vasospasm and atherosclerosis. Endothelin (10(-10) mol l-1-10(-7) mol l-1) produced dose-dependent contractions in both normal and diseased vessels. The level of constriction was significantly greatly in healthy vessels at 10(-8) mol l-1 endothelin. A greater response was recorded in smaller, more distal vessel segments, irrespective of the pathology of the tissue. Endothelium denudation of disease-free segments had no significant effect on the response to endothelin. In the presence of a threshold dose of endothelin (10(-9) mol l-1), there was no measurable increase in the tension generated by potassium chloride, the thromboxane-mimetic U46619, noradrenaline and histamine. However, the response to 5-HT showed a large increase in arteries from four patients (440-147%) but slight or no increase in arteries from another three patients. We conclude that the interaction with other vasoconstrictor substances is a possible mechanism whereby endothelin may be involved in coronary artery vasospasm. In addition, endothelin may also be involved in the regulation of vascular tone of the small vessels of the heart.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582446     DOI: 10.1111/j.1365-2362.1992.tb01828.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Role of endogenous endothelin in the regulation of basal coronary tone in the rat.

Authors:  A T Goodwin; M Amrani; C C Gray; J Jayakumar; M H Yacoub
Journal:  J Physiol       Date:  1998-09-01       Impact factor: 5.182

2.  Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.

Authors:  A Maassen VanDenBrink; W A Bax; M D Ferrari; F J Zijlstra; E Bos; P R Saxena
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Endothelin receptor expression and pharmacology in human saphenous vein graft.

Authors:  J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

4.  Evidence for heterogeneity of endothelin receptor distribution in human coronary artery.

Authors:  T Godfraind
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.

Authors:  J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 6.  Endothelin and myocardial ischemia.

Authors:  D Hasdai; R Kornowski; A Battler
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

7.  Different endothelin receptors involved in endothelin-1- and sarafotoxin S6B-induced contractions of the human isolated coronary artery.

Authors:  W A Bax; Z Aghai; C L van Tricht; C Wassenaar; P R Saxena
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.